Skip to main content

Table 7 Patient characteristics focusing on functional CMR results

From: Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach

  MD Normal LV and RV function Impaired LV and/or RV function p value
N = 63 N = 31 N = 32
Male, n (%) 63 (100) 31 (100) 32 (100) 1.00
Age, years 31 ± 15 27 ± 15 34 ± 15 0.11
BMD, n (%) 51 (81) 26 (84) 25 (78) 0.75
BMI, kg/m2 24 ± 4 24 ± 5 24 ± 3 0.72
Skeletal muscle status 0/1/2/3, n (%) 2 (3)/43 (68)/13 (21)/5 (8) 2 (7)/23 (74)/5 (16)/1 (3) 20 (63)/8 (25)/4 (13)/0 (0) 0.20
ACE inhibitor, n (%) 16 (25) 2 (7) 14 (44) 0.001
Beta-blocker, n (%) 14 (22) 4 (13) 10 (31) 0.13
CK, U/L 1226 (653–2424) 1250 (652–3043) 1221 (727–2291) 0.86
Elevated hs-Trop, n (%)a 30 (48) 8 (26) 22 (67) 0.001
Elevated NT-proBNP, n (%)b 3 (5) 0 (0) 3 (9) 0.24
  1. a > 14 pg/mL; b > 450 pg/mL
  2. Bold text indicates a significant p-value of <0.05